Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda.
Department of Laboratory Medicine, Faculty of Medicine and Health, WHO Collaborating Centre for Gonorrhoea and other STIs, National Reference Laboratory for STIs, Örebro University, Örebro, Sweden.
J Antimicrob Chemother. 2023 Aug 2;78(8):1982-1991. doi: 10.1093/jac/dkad193.
Global antimicrobial resistance (AMR) surveillance in Neisseria gonorrhoeae is essential. In 2017-18, only five (10.6%) countries in the WHO African Region reported to the WHO Global Gonococcal Antimicrobial Surveillance Programme (WHO GASP). Genomics enhances our understanding of gonococcal populations nationally and internationally, including AMR strain transmission; however, genomic studies from Africa are extremely scarce. We describe the gonococcal genomic lineages/sublineages, including AMR determinants, and baseline genomic diversity among strains in Uganda, Malawi and South Africa, 2015-20, and compare with sequences from Kenya and Burkina Faso.
Gonococcal isolates cultured in Uganda (n = 433), Malawi (n = 154) and South Africa (n = 99) in 2015-20 were genome-sequenced. MICs were determined using ETEST. Sequences of isolates from Kenya (n = 159), Burkina Faso (n = 52) and the 2016 WHO reference strains (n = 14) were included in the analysis.
Resistance to ciprofloxacin was high in all countries (57.1%-100%). All isolates were susceptible to ceftriaxone, cefixime and spectinomycin, and 99.9% were susceptible to azithromycin. AMR determinants for ciprofloxacin, benzylpenicillin and tetracycline were common, but rare for cephalosporins and azithromycin. Most isolates belonged to the more antimicrobial-susceptible lineage B (n = 780) compared with the AMR lineage A (n = 141), and limited geographical phylogenomic signal was observed.
We report the first multi-country gonococcal genomic comparison from Africa, which will support the WHO GASP and WHO enhanced GASP (EGASP). The high prevalence of resistance to ciprofloxacin (and empirical use continues), tetracycline and benzylpenicillin, and the emerging resistance determinants for azithromycin show it is imperative to strengthen the gonococcal AMR surveillance, ideally including genomics, in African countries.
全球淋病奈瑟菌(Neisseria gonorrhoeae)的抗菌药物耐药性(antimicrobial resistance,AMR)监测至关重要。2017-18 年,世卫组织非洲区域仅 5 个(10.6%)国家向世卫组织全球淋球菌抗菌药物监测规划(WHO GASP)报告。基因组学增强了我们对全国和国际范围内淋球菌群体的了解,包括 AMR 菌株的传播;然而,非洲的基因组学研究极为匮乏。我们描述了 2015-20 年乌干达、马拉维和南非的淋病奈瑟菌基因组谱系/亚谱系,包括 AMR 决定因素,以及菌株的基线基因组多样性,并与肯尼亚和布基纳法索的序列进行了比较。
2015-20 年在乌干达(n=433)、马拉维(n=154)和南非(n=99)培养的淋病奈瑟菌分离株进行基因组测序。采用 ETEST 法测定 MIC 值。分析中还包括来自肯尼亚(n=159)、布基纳法索(n=52)和 2016 年世卫组织参考菌株(n=14)的分离株序列。
所有国家的淋病奈瑟菌对环丙沙星的耐药率均较高(57.1%-100%)。所有分离株均对头孢曲松、头孢克肟和壮观霉素敏感,99.9%对阿奇霉素敏感。对环丙沙星、青霉素和四环素的 AMR 决定因素很常见,但对头孢菌素和阿奇霉素的 AMR 决定因素罕见。与 AMR 谱系 A(n=141)相比,大多数分离株属于更具抗菌药物敏感性的谱系 B(n=780),并且观察到有限的地理系统发育信号。
我们报告了非洲首例多国淋病奈瑟菌基因组比较,这将支持世卫组织 GASP 和世卫组织增强型 GASP(EGASP)。对环丙沙星(和经验性使用仍在继续)、四环素和青霉素的耐药率高,以及阿奇霉素的耐药决定因素不断出现,表明迫切需要加强非洲国家的淋球菌 AMR 监测,理想情况下包括基因组学。